Novel Radiation Approaches
- PMID: 33781503
- DOI: 10.1016/j.nec.2020.12.007
Novel Radiation Approaches
Abstract
The standard of care treatment for glioblastoma is surgical resection followed by radiotherapy to 60 Gy with concurrent and adjuvant temozolomide with or without tumor-treating fields. Advanced imaging techniques are under evaluation to better guide radiotherapy target volume delineation and allow for dose escalation. Particle therapy, in the form of protons, carbon ions, and boron neutron capture therapy, are being assessed as strategies to improve the radiotherapeutic ratio. Stereotactic, hypofractionated, pulsed-reduced dose-rate, and particle radiotherapy are re-irradiation techniques each uniquely suited for different clinical scenarios. Novel radiotherapy approaches, such as FLASH, represent promising advancements in radiotherapy for glioblastoma.
Keywords: Carbon ions; GBM; Glioblastoma; Protons; Radiation therapy; Radiotherapy; Trials.
Copyright © 2020 Elsevier Inc. All rights reserved.
Similar articles
-
Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial).J Neurooncol. 2018 Oct;140(1):75-82. doi: 10.1007/s11060-018-2932-3. Epub 2018 Jun 23. J Neurooncol. 2018. PMID: 29936695 Clinical Trial.
-
Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches.Chin J Cancer. 2014 Jan;33(1):16-24. doi: 10.5732/cjc.013.10217. Chin J Cancer. 2014. PMID: 24384237 Free PMC article. Review.
-
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial.Lancet Oncol. 2012 Sep;13(9):916-26. doi: 10.1016/S1470-2045(12)70265-6. Epub 2012 Aug 8. Lancet Oncol. 2012. PMID: 22877848 Clinical Trial.
-
Current status and recent advances in reirradiation of glioblastoma.Radiat Oncol. 2021 Feb 18;16(1):36. doi: 10.1186/s13014-021-01767-9. Radiat Oncol. 2021. PMID: 33602305 Free PMC article. Review.
-
Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.Int J Radiat Oncol Biol Phys. 1998 Mar 1;40(4):829-34. doi: 10.1016/s0360-3016(97)00891-2. Int J Radiat Oncol Biol Phys. 1998. PMID: 9531367 Clinical Trial.
Cited by
-
Optimizing the radiotherapy treatment planning process for glioblastoma.Neurooncol Pract. 2022 Jun 21;9(5):351-353. doi: 10.1093/nop/npac051. eCollection 2022 Oct. Neurooncol Pract. 2022. PMID: 36134014 Free PMC article. No abstract available.
-
CD99 Expression and Prognostic Impact in Glioblastoma: A Single-Center Cohort Study.Cells. 2024 Mar 29;13(7):597. doi: 10.3390/cells13070597. Cells. 2024. PMID: 38607036 Free PMC article.
-
How proton therapy fits into the management of adult intracranial tumors.Neuro Oncol. 2024 Mar 4;26(12 Suppl 2):S26-S45. doi: 10.1093/neuonc/noad183. Neuro Oncol. 2024. PMID: 38437667 Free PMC article. Review.
-
Pulsed-Reduced Dose Rate (PRDR) Radiotherapy for Recurrent Primary Central Nervous System Malignancies: Dosimetric and Clinical Results.Cancers (Basel). 2022 Jun 15;14(12):2946. doi: 10.3390/cancers14122946. Cancers (Basel). 2022. PMID: 35740612 Free PMC article.
-
Glitches in the brain: the dangerous relationship between radiotherapy and brain fog.Front Cell Neurosci. 2024 Mar 7;18:1328361. doi: 10.3389/fncel.2024.1328361. eCollection 2024. Front Cell Neurosci. 2024. PMID: 38515789 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical